Stephen Saad, Group Chief Executive, Aspen
The line between research based pharmaceutical companies and generic companies is today less and less relevant, as we have seen in the past few years generic companies climb up the…
Address: 378 Roan Crescent, Corporate Part North, Randjespark,South Africa
Tel: +27115429500
Web: http://www.lithahealthcare.co.za/company-structure/pharmaceuticals/litha-pharma/pharmafrica.html
Pharmafrica (Pty) Ltd has been in business since 1995. It became a full member of the Litha Group in 2010 but has been in a partnership with Litha since 2006.
The company markets ethical and complimentary healthcare products to niche markets through a wholesaler and direct distribution network. Pharmafrica has a solid reputation and strong relationships within the hospital and specialist environment and are an approved GMP manufacturer.
Pharmafrica is also a member of SMASA (Self Medication Manufacturers Association of South Africa)
Key markets:
Hospitals – Private and Public
Selected Medical Specialists and GP’s
Clinics – Private and Public
Academic Institutions
Retail Pharmacy
Pharmafrica has representatives in all the major areas of South Africa and primarily target the following specialities:
Cardiology
Dermatology
Plastic Surgery
Ophthalmology
Urology
General Medical Practice
Ethical medicines:
Analgesics
Anti-psychotics
Anti-depressants
Viscoelastic in eye surgery
Ophthalmic products
Anti-glaucoma therapy
Urinary incontinence
Topical anti-inflammatories
Complementary medicines:
Nutritive supplements
Vitamin supplements
Scar Management and stretch marks
Ageing and sun damaged skin preparations
Pharmafrica head office is located in Johannesburg and distributes from their warehouse nationally. They have a regional office in Cape Town and a total of 14 sales representatives. The company has regulatory, financial,/admin, marketing, distribution and sales resources and a total of 32 employees.
Pharmafrica represents the following companies:
Goldshield Pharmaceuticals – United Kingdom
Thornton & Ross LTD. – United Kingdom
Bio-technology General (B.T.G) – Israel
Apogepha Arzneimittel GMBH – Germany
Sankyo Pharma – Germany
Ursapharm – Germany
Products:
Cerumol – Ear Drops for ear care
Biolon Prime – Eye care
Biolone – Eye care
Ecotrin – Therapy for Cardiovascular Disease
Stelazine – Treatment of acute and chronic psychoses
Detrunorm – Therapy for an overactive bladder
Elmetacin – Topical NSAIDS
Dyazide – Treatment of fluid retention (edema) and high blood pressure (hypertension).
Diamox- Treatment for Glaucoma
Parnate – Antidepressant
Kamillosan – Baby care ointment
Oculet – Eye care
DS-24 – Nutritional supplement
Trimega – Omega Nutritional supplement
Dermastine Range – Skin and Scar Care
Flexeze Capsules and Gel – Therapy for Arthritis
The line between research based pharmaceutical companies and generic companies is today less and less relevant, as we have seen in the past few years generic companies climb up the…
Mr. Godard, you previously worked in Europe for Baxter Edwards Life Sciences, what made you decide to move to South Africa in a smaller company? It is a purely romantic…
Your professional career went back and forth between creating your own business and running a smaller and very dynamic structure and managing over a thousand of employees for multinational organizations.…
You were recently appointed at the head of Eli Lilly South African operations. What is the specific mission you have been given? Eli Lilly South Africa is in an interesting…
Since we interviewed you in 2005, there have been many changes in the market, from consolidation, an increasing generic penetration, to new healthcare reforms… How have you integrated these changes…
An emerging country with a dynamic market, South Africa is widely seen as the gateway to Africa. From major multinational pharmaceutical corporations to burgeoning local generic companies, a wide…
We interviewed Graham Somerville in 2004, the year when IHD, formerly jointly owned by 11 major pharmaceutical companies, was acquired by UTi. We are interviewing you today at the head…
Dr Pillay, South Africa recently became a member of BRICS. With this distinction, we need to improve our healthcare outcomes relative to other BRICS countries. All countries have challenges with…
The South African affiliate was established in June 2003. Could you come back on the main milestones in the company’s development from 2003 onwards? Yamanouchi as an entity was an…
Since we that came to South Africa in 2005 and interviewed you, what have been the main changes both in the market place, and within Sanofi as an organization? The…
In 2005, when Focus Reports interviewed you, you were more towards the start up phase of Pharma Dynamics; and you have significantly grown in the market since then. What new…
Mr. Ehsan, you are the General Manager of IMS Africa since January 2010. What is the strategic importance of South Africa for IMS Global and for your personal country portfolio?…
See our Cookie Privacy Policy Here
